E34.00

Clinical Causes: Development of carcinoid tumors, often in the small intestine, lungs, or other parts of the digestive system Abnormal production of hormones like serotonin, tachykinins, and prostaglandins by the tumor cells Genetic factors or family history that may predispose individuals to neuroendocrine tumors Previous exposure to certain carcinogens or radiation, although these are less common causes

Key Symptoms: Flushing of the skin, especially the face and neck Diarrhea that may be persistent or episodic Abdominal pain or cramping Wheezing or difficulty breathing due to bronchospasm Rapid heartbeat and high blood pressure during episodes Swelling in the face and neck (edema) Persistent skin rash or redness Unintended weight loss and fatigue

Diagnosis Path: The process of diagnosing carcinoid syndrome involves multiple steps, as symptoms can be nonspecific and similar to other conditions. Diagnostic methods include: - Blood tests measuring hormone levels, especially serotonin and chromogranin A - Urine tests for 5-hydroxyindoleacetic acid (5-HIAA), a serotonin metabolite - Imaging studies like computed tomography (CT), magnetic resonance imaging (MRI), or octreotide scans to locate tumors - Biopsy of suspected tumors to confirm neuroendocrine cell origin Early detection is crucial, but often the diagnosis is based on understanding clinical symptoms combined with laboratory and imaging findings.

Treatment Protocols: Management of carcinoid syndrome focuses on controlling symptoms and addressing the underlying tumor. Treatment options may include: - Surgical removal of tumors if feasible - Medication to control hormone secretion, such as somatostatin analogs (e.g., octreotide, lanreotide) - Symptomatic treatments for diarrhea and flushing - Targeted therapies or chemotherapy for advanced or metastatic tumors - Liver-directed therapies when tumors have spread to the liver - Regular monitoring and follow-up to detect recurrence or progression The choice of treatment depends on tumor location, extent, and overall patient health. Multidisciplinary care involving oncologists, endocrinologists, and surgeons is often essential.